Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
Status:
Terminated
Trial end date:
2016-12-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two different dosing regimens of phosphatidylcholine
versus placebo for the induction of remission in ulcerative colitis patients non-responsive
to standard mesalamine treatment.